Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CGT Global is a leading US-based provider of human primary cells, stem cells, bone marrow, cord blood, peripheral blood, and disease-state products. Their biospecimens are used globally in research and clinical trials supporting the development of cell and gene therapies. They operate GMP-certified labs and clinics across the US with a focus on accelerating access to advanced therapies by streamlining collection, processing, and delivery of high-quality biological materials for academic institutions, biotech/pharma companies, CROs/CDMOs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CGT Global.